Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Policy

    Policy - Page 2

    Gazette calls for registrations of medical devices, details

    Gazette calls for registrations of medical devices, details

    Farhat Nasim13 Feb 2020 11:30 AM IST
    New Delhi: Through a recent notification, the Union Health Ministry has mandated the registration of certain medical devices with the apex drug...
    All medical devices to be classified as DRUGS, details

    All medical devices to be classified as DRUGS, details

    Farhat Nasim12 Feb 2020 11:42 AM IST
    New Delhi: Through a recent gazette notification, the Union Health Ministry has notified medical equipment used on humans or animals as "drugs"...
    Capping Trade Margins of pharma would save Rs 984 crore, Ashwini Kumar Choubey informs LS

    Capping Trade Margins of pharma would save Rs 984 crore, Ashwini Kumar Choubey informs LS

    Farhat Nasim7 Feb 2020 4:53 PM IST
    There would be an annual saving of approx. Rs. 984 crores to the patients under 'Trade margin Rationalisation Approach' by the National Pharmaceutical...
    Overcharging on Anti-diabetic, Cardiac Care Drugs: Rs 245.96 crore recovered from Pharma Firms, Minister informs Parliament

    Overcharging on Anti-diabetic, Cardiac Care Drugs: Rs 245.96 crore recovered from Pharma Firms, Minister informs Parliament

    Farhat Nasim6 Feb 2020 4:43 PM IST
    NPPA has detected and issued about 162 demand notices against the pharmaceutical companies for overcharging consumers on the sale of Anti-diabetic and...
    NPPA pulls Gilead on price exemption plea for its Hepatitis B drug

    NPPA pulls Gilead on price exemption plea for its Hepatitis B drug

    Farhat Nasim4 Feb 2020 3:12 PM IST
    New Delhi: The apex drug price regulator, National Pharmaceuticals Pricing Authority (NPPA) has recently sought clarifications from the US-drugmaker...
    Zydus Cadila gets DGCI nod for diabetes drug Saroglitazar Magnesium

    Zydus Cadila gets DGCI nod for diabetes drug Saroglitazar Magnesium

    Farhat Nasim4 Feb 2020 10:30 AM IST
    "Zydus Cadila has received the approval from the Drug Controller General of India (DCGI) for use of Saroglitazar Mg in the treatment of type II...
    Emcure plea to direct NPPA to review HIV drugs price junked by DoP

    Emcure plea to direct NPPA to review HIV drugs price junked by DoP

    Farhat Nasim3 Feb 2020 1:41 PM IST
    New Delhi: In a setback to drugmaker Emcure Pharmaceuticals, the Department of Pharmaceuticals (DoP) has rejected the company's petition seeking to...
    NPPA fixes ceiling price of Immunoglobulin therapy, Details

    NPPA fixes ceiling price of Immunoglobulin therapy, Details

    Farhat Nasim2 Feb 2020 1:30 PM IST
    New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority, Ministry of Chemicals and Fertilizers, Government of India has...
    Essential medicines price capping resulted in saving of Rs 12500 crore, says Kovind

    Essential medicines price capping resulted in saving of Rs 12500 crore, says Kovind

    Farhat Nasim2 Feb 2020 12:00 PM IST
    Addressing the joint sitting of both houses of Parliament, on the first day of the Budget session here, Kovind said capping of prices of more than...
    DCGI releases list of Reference Products for conduct of BE Study, details

    DCGI releases list of Reference Products for conduct of BE Study, details

    Medical Dialogues Bureau25 Jan 2020 2:25 PM IST
    New Delhi: Through a recent notice, Drug Controller General of India has released the List of Products Permitted by DCG(I) and considered as Reference...
    Drugs and Magic Remedies act to cover online, electronic media; have higher penalties

    Drugs and Magic Remedies act to cover online, electronic media; have higher penalties

    Farhat Nasim19 Jan 2020 11:15 AM IST
    New Delhi: In a stringent view to regulate the menace of misleading advertisements opted tactfully by many companies to enhance the sale of their...
    FICCI raises concern on delay by govt in notifying E-pharmacy rules

    FICCI raises concern on delay by govt in notifying E-pharmacy rules

    Meghna A Singhania17 Jan 2020 12:33 PM IST
    NEW DELHI: With the ongoing delay in the notification of e-Pharmacy draft rules, industry body FICCI has recently show concern pointing out that the...
    PrevNext

    Popular Stories

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    India should become self-reliant in medical equipment, devices: Kasturirangan

    India should become self-reliant in medical equipment, devices: Kasturirangan

    Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral treatment

    Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral...

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    Coronavirus Impact: Indian Pharma Exports to miss 22 Billion target, says Pharmexcil

    Coronavirus Impact: Indian Pharma Exports to miss 22 Billion target, says Pharmexcil

    Lasa Supergenerics gets FDA nod for Progesterone

    Lasa Supergenerics gets FDA nod for Progesterone

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok